These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12493791)

  • 1. Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.
    Ellbogen MH; Olsen KM; Gentry-Nielsen MJ; Preheim LC
    J Antimicrob Chemother; 2003 Jan; 51(1):83-91. PubMed ID: 12493791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia.
    Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry MJ
    Alcohol Clin Exp Res; 1999 May; 23(5):842-9. PubMed ID: 10371404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
    Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry-Nielsen MJ
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):103-11. PubMed ID: 15698715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia.
    Olsen KM; Gentry-Nielsen M; Yue M; Snitily MU; Preheim LC
    Antimicrob Agents Chemother; 2006 Jan; 50(1):210-9. PubMed ID: 16377688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia.
    Gentry-Nielsen MJ; Olsen KM; Preheim LC
    Antimicrob Agents Chemother; 2002 May; 46(5):1345-51. PubMed ID: 11959567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
    Antimicrob Agents Chemother; 2001 May; 45(5):1487-92. PubMed ID: 11302815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.
    Yoshioka D; Kajiwara C; Ishii Y; Umeki K; Hiramatsu K; Kadota J; Tateda K
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6146-54. PubMed ID: 27480866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.
    Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2575-81. PubMed ID: 12121935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
    Choi G; Hofstra JJ; Roelofs JJ; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; van der Poll T; Levi M; Schultz MJ
    Crit Care Med; 2008 Jan; 36(1):204-10. PubMed ID: 18090375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local inflammation alters the lung disposition of a drug loaded pegylated liposome after pulmonary dosing to rats.
    Haque S; Feeney O; Meeusen E; Boyd BJ; McIntosh MP; Pouton CW; Whittaker M; Kaminskas LM
    J Control Release; 2019 Aug; 307():32-43. PubMed ID: 31152749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia.
    Wang E; Bergeron Y; Bergeron MG
    J Antimicrob Chemother; 2005 May; 55(5):721-6. PubMed ID: 15772139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia.
    Yanagihara K; Fukuda Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Tsukamoto K; Yamada Y; Kamhira S; Kohno S
    Exp Lung Res; 2007 Mar; 33(2):71-80. PubMed ID: 17454103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects.
    Chono S; Tanino T; Seki T; Morimoto K
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1090-6. PubMed ID: 18777242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.
    Wong JP; Yang H; Blasetti KL; Schnell G; Conley J; Schofield LN
    J Control Release; 2003 Oct; 92(3):265-73. PubMed ID: 14568408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration.
    Liu C; Shi J; Dai Q; Yin X; Zhang X; Zheng A
    Drug Dev Ind Pharm; 2015 Feb; 41(2):272-8. PubMed ID: 24252110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced hypothermia is protective in a rat model of pneumococcal pneumonia associated with increased adenosine triphosphate availability and turnover*.
    Beurskens CJ; Aslami H; Kuipers MT; Horn J; Vroom MB; van Kuilenburg AB; Roelofs JJ; Schultz MJ; Juffermans NP
    Crit Care Med; 2012 Mar; 40(3):919-26. PubMed ID: 22036856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct examination and cultures of bronchoalveolar lavage in pneumonia diagnosis: a comparative experimental study.
    Brandão da Silva N; Martins L; Martins F; Anflor J; Tonietto T; Koefender C; Cardoso PG; Moreira J
    Intensive Care Med; 2007 Oct; 33(10):1840-7. PubMed ID: 17673974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar.
    Ishida Y; Kurosaka Y; Murakami Y; Otani T; Yamaguchi K
    Chemotherapy; 1999; 45(3):183-91. PubMed ID: 10224340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.
    Wang E; Simard M; Ouellet N; Bergeron Y; Beauchamp D; Bergeron MG
    J Infect Dis; 2000 Oct; 182(4):1255-9. PubMed ID: 10979929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.